Gene Yeo

Eugene (Gene) Yeo is a Professor of Cellular and Molecular Medicine at the University of California San Diego and a Visiting Professor at the National University of Singapore. Gene’s research interest is in understanding and manipulating RNA processing in development and disease using induced pluripotent stem cells and animal models. Dr. Yeo has authored more than 150 peer-reviewed publications in the areas of neurodegeneration, RNA processing, computational biology and stem cell models. His lab developed enhanced CLIP for the purposes of large-scale mapping of protein-RNA interactions and importantly, demonstrated in vivo RNA targeting with CRISPR/Cas proteins with proof of concept in repeat expansion disorders. Gene is on the Editorial Boards of the journals Cell Reports and Cell Research. Gene’s research has been funded by the National Institute of Health, National Science Foundation, California Institute for Regenerative Medicine, Target ALS, ALS Foundation, Myotonic Dystrophy Association, Myotonic Dystrophy Foundation and Chan-Zuckerberg Initiative. He is a co-founder of multiple biotech companies, which include Locana, Eclipse Bioinnovations, Enzerna and Proteona. Gene serves or has served on the scientific advisory boards of the Allen Institute of Immunology, Locana, Eclipse Bioinnovations, Proteona, Aquinnah, Cell Applications, Nugen and Ribometrix. Gene earned a PhD in Computational Neuroscience from MIT and an MBA from the UCSD Rady School of Management.